Cepheid (NASDAQ:CPHD)

CAPS Rating: 2 out of 5

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

Recs

0
Player Avatar almodovar (< 20) Submitted: 6/22/2012 5:32:57 PM : Outperform Start Price: $42.38 CPHD Score: -23.29

Product is in demand.

Featured Broker Partners


Advertisement